logo
16:01 Jan 20

Everest Organics Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
435.00
+2.50 (+0.58%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Everest Organics Ltd. Financials

Everest Organics Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
435.00
+2.50 (+0.58%)
16:01 Jan 20
Quality
image/svg+xml

41/100
Medium Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

48/100
Technically Neutral

Strength

2

Weakness

7

Opportunity

0

Threats

0

-1.84 %

ROE %

-0.57 %

ROA %

0.00

EPS

72.03

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
181.57 200.05 183.05 197.24 159.48
Operating Expenses +
158.72 193.62 182.12 186.25 152.26
Raw Material
115.99 140.36 124.9 123.41 97.5
Increase Decrease in Cost
-8.22 -4.51 -3.23 0.56 1.04
Other Manufacturing Expense
26.17 30.38 32.44 30.66 0
Employee Cost
15.26 16.33 16.3 18.8 16.35
Miscellaneous Expenses
9.52 11.06 11.71 12.82 37.37
Operating Profit
22.85 6.43 0.93 10.99 7.22
Other Income
1.06 2.21 6.94 0.89 0.69
Depreciation
3.37 3.8 4.47 5.8 5.96
Interest
3.26 3.1 3.31 5.47 5.19
Profit before tax and exceptio..
17.27 1.74 0.09 0.61 -3.24
Exceptional Items
0 0 0 0 0
PBT
17.27 1.74 0.09 0.61 -3.24
Provision for Taxation
3.56 0.6 0.27 0.47 -1.95
Net Profit
13.71 1.14 -0.18 0.14 -1.29
NET Profit after MI
0 0 0 0 0
EPS
17.14 1.43 -0.23 0.17 -2.97
Operating Profit Margin (%)
12.58 3.21 0.51 5.57 4.53
Net Profit Margin (%)
7.55 0.57 -0.1 0.07 -0.81

Everest Organics Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 59.60 59.60 61.00 61.10 74.20 74.20
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 40.40 40.40 39.00 38.90 25.80 25.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: